News

Stay informed about our latest innovations, products and scientific news. Learn more about Eurofins CALIXAR through our press releases and biotech events and find out why we are at the forefront of protein technology.

News
April 12, 2021

Calixar invests €1 million in pipeline of highly druggable membrane protein targets and native antigens

News
April 6, 2021

CALIXAR and CliniSciences Group finalize a distribution agreement

News
March 30, 2021

CALIXAR and BioD Co., Ltd. finalize a distribution agreement

News
March 19, 2021

CALIXAR and Amerigo SCIENTIFIC finalize a distribution agreement

Events
March 11, 2021

CALIXAR will attend the Festival of Biologics USA on March 29 – April 1, 2021

News
March 8, 2021

CALIXAR highlighted as a key player on the Global Difficult-to-Express Proteins Market in 2021

News
February 23, 2021

CALIXAR and the Austrian Institute of Technology, to improve the diagnosis of emerging and infectious diseases

News
February 10, 2021

CALIXAR recognized as a major player on the global antibody engineering services market

News
January 19, 2021

CALIXAR and AFSBio finalize a distribution agreement

News
January 12, 2021

Happy New Year 2021!

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.